Celebrating our 10th anniversary – Unlock our special offer today

Synthetic nicotine – a manufactured scare story with nothing to be afraid of

While synthetic nicotine has become the focus of much controversy, demonised as a public health risk, its currently poor reputation derives more from bureaucracy than from the substance itself.

Studies suggest synthetic nicotine is as safe as the tobacco-derived kind, which itself has very little impact on health, other than being as addictive as, say, caffeine.

The recent US spotlight on synthetic nicotine derives entirely from the fact that it fails to fit the definition of a “tobacco product” and so has until now escaped US Food and Drug Administration (FDA) oversight.

Read full article
I'm already a subscriber
Author default picture

TobaccoIntelligence

This article was written by one of TobaccoIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual nicotine markets.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation